吡柔比星治疗恶性血液病致心肌损害的分析
被引量:5
摘要
毗柔比星作为一种疗效肯定的抗恶性肿瘤药物在临床上已得到广泛应用,但作为一种蒽环类药物,其心肌损害也不容忽视。现分析我院收治的50例恶性血液病患者应用含吡柔比星方案化疗后出现的心肌损害情况。
出处
《天津医药》
CAS
北大核心
2009年第9期796-797,共2页
Tianjin Medical Journal
参考文献6
-
1Wolf MB, Baynes JW.The anti-cancer drug, doxorubicin,causes oxidant stress-induced endothelial dysfunction. Biochim [J]. Biophys Acta,2006,1760 ( 2 ) :267 -271.
-
2Kotamraju S, Kalivendi SV, Konorev E,et al. Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis [J]. Methods Enzymol, 2004,378 (1):362-382.
-
3Simunek T, Sterba M, Holeckova M, et al.Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits[J]. Biometals, 2005,18 (2): 163-169.
-
4Swain SM,Whaley FS,Ewer MS. Congestive heart failure in patients treated with Doxorubicin: a retrospective analysis of three trials[J]. Canaer, 2003, 97(11):2869-2879.
-
5Kiliekap S, Barista I,Akgul E,et al. eTnT can be a useful marker for early detection of anthracycline cardiotoxicity[J]. Ann Oncol,2005, 16 ( 5 ) :798-804.
-
6Takemura G,Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management[J]. Prog Cardiovasc Dis, 2007,49 (5) : 330-352.
同被引文献46
-
1陈冀莹.心肌损伤标志物的应用及临床意义[J].国外医学(放射医学核医学分册),2004,28(5):216-219. 被引量:17
-
2宋斌,黄山杉,刘庆国,冯顺乔,李婷,杜洋,邢嵘.红景天苷对大鼠心肌缺血再灌注损伤的保护作用[J].辽宁中医杂志,2005,32(3):256-258. 被引量:44
-
3Otterstad JE.Measuring left ventricular volume and ejection fraction with the biplane Simpson's method[J].Heart,2002,88(6):559-560.
-
4Adams M J,Lipshultz SE.Pathophysiology of anthracycline and radiation associated cardiomyopathies:implications for screening and prevention[J].Pediatr Blood Cancer,2005,44(7):600-606.
-
5Mohammad GI,Al Menshawy AM,Abd El Hakeem EE,et al.The value of biochemical markers in evaluation of myocardial damage in children[J].Eng J Anaesth,2003,19(1):1-8.
-
6Swain SM,Whaley FS,Ewer MS.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trails[J].Cancer,2003,97(11):2869-2879.
-
7Zuber M,Gerber K,Erne P,et al.Myocardial tissue characterization in heart failure by real-time integrated backscatter[J].Eur J Ultra,1999,9(2):135-143.
-
8JE Otterstad. Measuring left ventricular volume and ejection fractior/with the biplane Simpson's method[J]. Heart, 2002, 88(6): 559-560.
-
9Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trails [J]. Cancer, 2003, 97: 2869-2879.
-
10Adams M J, Lipshultz SE. Pathophysiology of anthracycline-and-radiation associated cardiomyopathies.. implications for screening and prevention [J]. Pediatr Blood Cancer, 2005, 44(7): 600-606.
引证文献5
-
1沈伟生,高春恒,张华,邓立春,袁明,张瑶,奚蕾.红景天对含表柔比星方案化疗患者的血清肌钙蛋白Ⅰ、心肌背向散射积分及左室射血分数的影响[J].中国中西医结合杂志,2010,30(12):1250-1252. 被引量:5
-
2沈伟生,高春恒,张华,邓立春,袁明,张瑶,奚蕾,盛华明.红景天预防含表柔比星方案化疗所致心脏毒性临床观察[J].新中医,2012,44(2):18-20. 被引量:11
-
3姚诗清,戴小华,周兰.补气活血法防治表柔比星致心脏毒性的临床研究[J].中华全科医学,2013,11(3):437-438. 被引量:6
-
4高颖,陆亚红,屠丹丽.一例白血病患儿使用蒽环类化疗药并发阵发性室上性心动过速的护理[J].中国实用护理杂志,2017,33(4):293-295. 被引量:1
-
5王迎虎,邵兆军,刘强,何伟,杨会红.CT引导下三叉神经节低温热凝射频术联合吡柔比星注射治疗原发性三叉神经痛的回顾性分析[J].实用疼痛学杂志,2018,0(2):101-104. 被引量:1
二级引证文献21
-
1沈伟生,高春恒,张华,邓立春,袁明,张瑶,奚蕾,盛华明.红景天预防含表柔比星方案化疗所致心脏毒性临床观察[J].新中医,2012,44(2):18-20. 被引量:11
-
2叶应琴,李惠新.红景天甙抗肿瘤作用的研究进展[J].临床荟萃,2012,27(7):642-644. 被引量:2
-
3屈强.参附注射液对表柔比星化疗患者心脏毒性的影响[J].肿瘤基础与临床,2012,25(3):262-263. 被引量:5
-
4姚诗清,戴小华,周兰.补气活血法防治表柔比星致心脏毒性的临床研究[J].中华全科医学,2013,11(3):437-438. 被引量:6
-
5黄种新,杜好信.中医药对乳腺癌化疗副作用的治疗概况[J].中医药通报,2013,12(2):64-66. 被引量:3
-
6陈莉莉,张晗,姜小庆,王小莹.中药有效成分拮抗化疗药物心脏毒性的分子机制研究进展[J].辽宁中医杂志,2013,40(11):2387-2391. 被引量:5
-
7李艳阳,孙海燕,姜战胜,岳振松,王斌,李燕巍,兰岚,刘东颖,闫祝辰,谢广茹,潘战宇.中医药防治抗肿瘤药物心脏毒性的研究[J].中国中医基础医学杂志,2018,24(11):1602-1606. 被引量:19
-
8白海,王存邦,马晓慧,魏玉萍,葸瑞,赵强,张茜.红景天苷对骨髓间充质干细胞增殖的影响[J].中国实验血液学杂志,2014,22(4):1072-1077. 被引量:6
-
9雷英瑛,郭小红,刘利,周凡.红景天辅助抗肿瘤作用研究进展[J].医药导报,2014,33(10):1344-1347. 被引量:3
-
10郝炜,刘胜.中医药防治蒽环类抗肿瘤药物所致心脏毒性研究进展[J].上海中医药杂志,2016,50(6):99-102. 被引量:16
-
1王建伟,齐国庆,喻宗敏.中晚期肝细胞癌肝动脉化疗栓塞术后近期肝功能转归的影响探析[J].中国医药指南,2013,11(6):504-505. 被引量:1
-
2张伟,刘向东,吴文娟,李海涛,张泽坤,樊新云.三氧化二砷介入治疗骨转移瘤疗效观察[J].河北医药,2008,30(1):34-35. 被引量:2
-
3黄嵊,王益民,杨皓.超声检查对胃肠道肿瘤的诊断价值[J].医药前沿,2017,7(3):80-81. 被引量:1
-
4王倩,李玉峰.高三尖杉酯碱对伊马替尼耐药的慢性髓系白血病疗效的研究进展[J].中国实验血液学杂志,2017,25(2):596-599. 被引量:6
-
5郑文,勇威本,朱军,张运涛,王小沛,谢彦.非霍奇金淋巴瘤肝损害临床分析[J].中国肿瘤临床,2004,31(13):767-769. 被引量:3
-
6邵维维,周笳,付蓉,邵宗鸿.蒽环类药物治疗非霍奇金淋巴瘤心脏毒性的临床研究[J].中华血液学杂志,2009,30(7):491-492.
-
7庄炜钊,黄晨,姬智艳,林淑仪,黄益,唐郁宽,冯惠岗.TACE联合氩氦刀冷冻消融治疗中晚期肝癌的疗效分析[J].医学影像学杂志,2016,26(12):2247-2250. 被引量:19
-
8李金燕,任欣乐,白星,朱兵.紫杉醇、奈达铂联合化疗治疗晚期食管癌的临床观察[J].中国临床研究,2014,27(9):1072-1073. 被引量:4
-
9赵艳飞,于跃利,兰明阳,贾志勇.肿瘤多药耐药性及其逆转策略[J].包头医学院学报,2009,25(6):101-103. 被引量:3
-
10陈静,张遂亮.肝癌患者TACE术后肝功能损害的调查研究[J].实用临床医药杂志,2017,21(4):202-204. 被引量:9